Suppr超能文献

验证脑肿瘤报告与数据系统(BT-RADS)作为胶质瘤术后随访诊断工具的有效性。

Validating Brain Tumor Reporting and Data System (BT-RADS) as a Diagnostic Tool for Glioma Follow-Up after Surgery.

作者信息

Almalki Yassir Edrees, Basha Mohammad Abd Alkhalik, Metwally Maha Ibrahim, Zeed Nesma Adel, Nada Mohamad Gamal, Alduraibi Sharifa Khalid, Morsy Ahmed A, Balata Rawda, Al Attar Ahmed Z, Amer Mona M, Farag Mohamed Abd El-Aziz Mohamed, Aly Sameh Abdelaziz, Basha Ahmed M Abdelkhalik, Hamed Enas Mahmoud

机构信息

Division of Radiology, Department of Internal Medicine, Medical College, Najran University, Najran 61441, Saudi Arabia.

Department of Diagnostic Radiology, Faculty of Human Medicine, Zagazig University, Zagazig 44519, Egypt.

出版信息

Biomedicines. 2024 Apr 17;12(4):887. doi: 10.3390/biomedicines12040887.

Abstract

Gliomas are a type of brain tumor that requires accurate monitoring for progression following surgery. The Brain Tumor Reporting and Data System (BT-RADS) has emerged as a potential tool for improving diagnostic accuracy and reducing the need for repeated operations. This prospective multicenter study aimed to evaluate the diagnostic accuracy and reliability of BT-RADS in predicting tumor progression (TP) in postoperative glioma patients and evaluate its acceptance in clinical practice. The study enrolled patients with a history of partial or complete resection of high-grade glioma. All patients underwent two consecutive follow-up brain MRI examinations. Five neuroradiologists independently evaluated the MRI examinations using the BT-RADS. The diagnostic accuracy of the BT-RADS for predicting TP was calculated using histopathology after reoperation and clinical and imaging follow-up as reference standards. Reliability based on inter-reader agreement (IRA) was assessed using kappa statistics. Reader acceptance was evaluated using a short survey. The final analysis included 73 patients (male, 67.1%; female, 32.9%; mean age, 43.2 ± 12.9 years; age range, 31-67 years); 47.9% showed TP, and 52.1% showed no TP. According to readers, TP was observed in 25-41.7% of BT-3a, 61.5-88.9% of BT-3b, 75-90.9% of BT-3c, and 91.7-100% of BT-RADS-4. Considering >BT-RADS-3a as a cutoff value for TP, the sensitivity, specificity, and accuracy of the BT-RADS were 68.6-85.7%, 84.2-92.1%, and 78.1-86.3%, respectively, according to the reader. The overall IRA was good (κ = 0.75) for the final BT-RADS classification and very good for detecting new lesions (κ = 0.89). The readers completely agreed with the statement "the application of the BT-RADS should be encouraged" (score = 25). The BT-RADS has good diagnostic accuracy and reliability for predicting TP in postoperative glioma patients. However, BT-RADS 3 needs further improvements to increase its diagnostic accuracy.

摘要

胶质瘤是一种脑肿瘤,术后需要对其进展进行准确监测。脑肿瘤报告和数据系统(BT-RADS)已成为提高诊断准确性和减少重复手术需求的一种潜在工具。这项前瞻性多中心研究旨在评估BT-RADS在预测术后胶质瘤患者肿瘤进展(TP)方面的诊断准确性和可靠性,并评估其在临床实践中的接受度。该研究纳入了有高级别胶质瘤部分或完全切除病史的患者。所有患者均接受了连续两次的脑部MRI随访检查。五名神经放射科医生使用BT-RADS对MRI检查进行独立评估。以再次手术后的组织病理学以及临床和影像学随访作为参考标准,计算BT-RADS预测TP的诊断准确性。使用kappa统计量评估基于阅片者间一致性(IRA)的可靠性。通过简短调查评估阅片者的接受度。最终分析纳入了73例患者(男性占67.1%;女性占32.9%;平均年龄43.2±12.9岁;年龄范围31 - 67岁);47.9%出现TP,52.1%未出现TP。根据阅片者的判断,在BT-3a中观察到TP的比例为25 - 41.7%,BT-3b中为61.5 - 88.9%,BT-3c中为75 - 90.9%,BT-RADS-4中为91.7 - 100%。将>BT-RADS-3a作为TP的截断值,根据阅片者的判断,BT-RADS的敏感性、特异性和准确性分别为68.6 - 85.7%、84.2 - 92.1%和78.1 - 86.3%。最终BT-RADS分类的总体IRA良好(κ = 0.75),检测新病变的IRA非常好(κ = 0.89)。阅片者完全同意“应鼓励应用BT-RADS”这一说法(得分 = 25)。BT-RADS在预测术后胶质瘤患者TP方面具有良好的诊断准确性和可靠性。然而,BT-RADS 3需要进一步改进以提高其诊断准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfbd/11048183/f5f8c0cddf07/biomedicines-12-00887-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验